Related Experiment Video
Updated: Mar 21, 2026
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
27.8K
Fecal transplantation indications in ulcerative colitis. Preliminary study.
Mihaela Laszlo1, Lidia Ciobanu2, Vasile Andreica2
1Regional Institute of Gastroenterology and Hepatology, Cluj-Napoca, Romania; Gastroenterology and Hepatology Medical Center, Cluj-Napoca, Romania.
Clujul Medical (1957)
|May 7, 2016
Summary
Fecal microbiota transplantation offers a promising alternative for young ulcerative colitis patients unresponsive to conventional treatments. This therapy achieved sustained remission in multiple cases, highlighting its potential as a salvage treatment.
Area of Science:
- Gastroenterology
- Microbiome Research
- Immunology
Background:
- Fecal microbiota transplantation (FMT) is established for recurrent Clostridium Difficile Infection.
- Its application in inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease, is emerging.
- Theoretical benefits support FMT in IBD, particularly for patients with limited treatment options.
Purpose of the Study:
- To evaluate the indications for FMT in young patients with ulcerative colitis and multiple relapses.
- To assess FMT efficacy in patients refractory to biological or immunosuppressive therapies.
Main Methods:
- Fecal microbiota transplantation was administered via colonoscopy to five patients with moderate-to-severe UC.
- Patients had lost therapeutic response to biological therapy and/or immunosuppression.
- Healthy family members served as donors for the FMT.
Main Results:
- All patients achieved clinical remission, with complete remission sustained for at least 10 months.
- Endoscopic improvements were observed in ulcer appearance.
- Two patients experienced diminished FMT effects after 10-12 months, necessitating reintroduction of systemic therapy.
Conclusions:
- Fecal microbiota transplantation serves as effective salvage therapy for biologic-refractory patients.
- FMT is a viable alternative for young UC patients hesitant about biological or immunosuppressive treatments.
- The study demonstrates FMT's potential in managing complex UC cases.
